MedPath

Research of mechanism and cytotoxicity of newly-developed anticancer drug for gastric cancer using human gastric cells.

Not Applicable
Recruiting
Conditions
Gastric cancer
Registration Number
JPRN-UMIN000022844
Lead Sponsor
Asahikawa Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

The subjects who are judged to be inappropriate for this study by doctors conducting the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes of the cancer cell count after the treatment of newly-developed anticancer drug.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath